Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obstetrics and Gynecology Reports
Published in: Current Obstetrics and Gynecology Reports 2/2024

10-04-2024 | Fertility | REVIEW

Laparoscopic Radiofrequency Fibroid Ablation: A Review of Current Use and Future Applications

Authors: Natalie D. Cohen, Emily Lin, Jessica K. Shields, Kimberly A. Kho

Published in: Current Obstetrics and Gynecology Reports | Issue 2/2024

Login to get access

Abstract

Purpose of Review

Laparoscopic radiofrequency ablation (Lap-RFA), which was FDA-cleared for the management of symptomatic uterine fibroids in 2012, offers a promising minimally invasive option for the treatment of fibroids. Although a relatively new technology, there is a substantial amount of literature that indicates it is a safe, effective option that has decreased operative time when compared to laparoscopic myomectomy, a low likelihood of complication, and a high chance of sustained reduction of fibroid burden for patients. We present the current literature that evaluates Lap-RFA in its current use, as well as present the future of the technology.

Recent Findings

The current literature demonstrates that Lap-RFA succeeds in treating a large amount of FIGO 2–6 fibroids with clinical improvements in fibroid volume, menstrual blood loss, dysmenorrhea, fibroid-related symptom scores, and overall quality of life. Some data indicates that the technology may be safe for patients who desire future fertility or have adenomyosis, though large trials have yet to be performed.

Summary

Lap-RFA offers promising long-term data that demonstrate treatment effectiveness is robust with relatively low complication rates. There are many possible future directions of research for this technology, including its use with patients who desire future fertility or have adenomyosis, as well as in combination with other treatments of fibroids.
Literature
1.
Eltoukhi HM, Modi MN, Weston M, Armstrong AY, Stewart EA. The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol. 2014;210(3):194–9.CrossRefPubMed
2.
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.CrossRefPubMed
3.
Halt Medical Inc. FDA 510(k) Summary and Letter for Acessa System. 2012 Nov.
4.
• Chudnoff SG, Berman JM, Levine DJ, Harris M, Guido RS, Banks E. Outpatient procedure for the treatment and relief of symptomatic uterine myomas. Obstetrics and Gynecology. 2013;121(5):1075–82. This is the initial large cohort trial examining the safety and efficacy of Lap-RFA which revealed the procedure to be well tolerated with effective symptom relief.CrossRefPubMed
5.
Guido RS, Macer JA, Abbott K, Falls JL, Tilley IB, Chudnoff SG. Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years’ outcome from the Halt trial. Health Qual Life Outcomes. 2013;13(11):139.CrossRef
6.
Goldfarb HA. Laparoscopic coagulation of myoma (myolysis). Obstet Gynecol Clin North Am. 1995;22(4):807–19.CrossRefPubMed
7.
Lee BB. Radiofrequency ablation of uterine leiomyomata: a new minimally invasive hysterectomy alternative. Obstetrics & Gynecology. 2002;9(S):99.
8.
9.
Gynesonics Inc. FDA 510(k) Summary and Letter for SONATA System. 2018 Aug.
10.
Brucker SY, Hahn M, Kraemer D, Taran FA, Isaacson KB, Krämer B. Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy. Int J Gynaecol Obstet. 2014;125(3):261–5.CrossRefPubMed
11.
• Rattray DD, Weins L, Regush LC, Bowen JM, O’Reilly D, Thiel JA. Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada. Clinicoecon Outcomes Res. 2018;10:201–12. A study comparing Lap-RFA with laparoscopic myomectomy, found Lap-RFA to be associated with less intraoperative blood loss and shorter procedure and hospitalization times with comparable direct and indirect costs.CrossRefPubMedPubMedCentral
12.
• Bradley LD, Pasic RP, Miller LE. Clinical performance of radiofrequency ablation for treatment of uterine fibroids: systematic review and meta-analysis of prospective studies. J Laparoendosc Adv Surg Tech A. 2019;29(12):1507–17. A systematic review and meta-analysis of radiofrequency ablation noted a significant reduction in fibroid volume, improvements in quality of life, and favorable reintervention rates.CrossRefPubMedPubMedCentral
13.
Lin L, Ma H, Wang J, Guan H, Yang M, Tong X, et al. Quality of life, adverse events, and reintervention outcomes after laparoscopic radiofrequency ablation for symptomatic uterine fibroids: a meta-analysis. J Minim Invasive Gynecol. 2019;26(3):409–16.CrossRefPubMed
14.
Braun KM, Sheridan M, Latif EZ, Regush L, Maksymowicz A, Weins L, et al. Surgeons’ early experience with the AcessaTM procedure: gaining proficiency with new technology. Int J Womens Health. 2016;8:669–75.CrossRefPubMedPubMedCentral
15.
Jacoby VL, Parvataneni R, Oberman E, Saberi NS, Varon S, Schembri M, et al. Laparoscopic radiofrequency ablation of uterine leiomyomas: clinical outcomes during early adoption into surgical practice. J Minim Invasive Gynecol. 2020;27(4):915–25.CrossRefPubMed
16.
Yu S, Silverberg K, Bhagavath B, Shobeiri SA, Propst A, Eisenstein D. Post-market safety of laparoscopic ultrasound-guided radiofrequency ablation. JSLS. 2020;24(4).
17.
Berman JM, Guido RS, Garza Leal JG, Pemueller RR, Whaley FS, Chudnoff SG, et al. Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. J Minim Invasive Gynecol. 2014;21(5):767–74.CrossRefPubMed
18.
• Polin M, Hur HC. Radiofrequency ablation of uterine myomas and pregnancy outcomes: an updated review of the literature. J Minim Invasive Gynecol. 2022;29(6):709–15. A systematic review on 50 pregnancy outcomes after laparoscopic and transcervical radiofrequency ablation.CrossRefPubMed
19.
Young RJ, Puma L, Latham M, Kho KA. Radiofrequency ablation for treatment of leiomyomas: review of the Manufacturer and User Facility Device Experience (MAUDE) database. Obstetrics and Gynecology. 2023;142(1):147–50.CrossRefPubMed
20.
Baxter BL, Seaman SJ, Arora C, Kim JH. Radiofrequency ablation methods for uterine sparing fibroid treatment. Curr Opin Obstet Gynecol. 2022;34(4):262–9.CrossRefPubMed
21.
Lin E, Sendukas E, Kho KA. Postoperative uterine necrosis and peritonitis following laparoscopic radiofrequency myoma ablation. J Minim Invasive Gynecol. 2022;29(10):1123–4.CrossRefPubMed
22.
Niddam R, Netter A, Gauthier A, Calderon L, Agostini A, Miquel L. postoperative rectal necrosis after laparoscopic multibipolar radiofrequency myoma ablation. J Minim Invasive Gynecol. 2023;30(6):433–5.CrossRefPubMed
23.
Yu S, Bhagavath B, Shobeiri SA, Eisenstein D, Levy B. Clinical and patient reported outcomes of pre- and postsurgical treatment of symptomatic uterine leiomyomas: a 12-month follow-up review of TRUST, a surgical randomized clinical trial comparing laparoscopic radiofrequency ablation and myomectomy. J Minim Invasive Gynecol. 2022;29(6):726–37.CrossRefPubMed
24.
Davis MR, Soliman AM, Castelli-Haley J, Snabes MC, Surrey ES. Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids. J Womens Health (Larchmt). 2018;27(10):1204–14.CrossRefPubMedPubMedCentral
25.
Scarperi S, Pontrelli G, Campana C, Steinkasserer M, Ercoli A, Minelli L, et al. Laparoscopic radiofrequency thermal ablation for uterine adenomyosis. JSLS. 2015;19(4).
26.
Lin XL, Hai N, Zhang J, Han ZY, Yu J, Liu FY, et al. Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis. Int J Hyperthermia. 2020;37(1):151–6.CrossRefPubMed
27.
Abdel-Fattah H, El-Lakkany N, Helal AS, Mosbah A, Abdel-Hady ES, Abdel-Shaheed M. Conservative laparoscopic electrocoagulation adenomyolysis for the management of symptomatic adenomyosis. Gynecol Surg. 2015;12(3):139–47.CrossRef
28.
Bongers M, Gupta J, Garza-Leal JG, Brown M, Felberbaum R. The INTEGRITY trial: preservation of uterine-wall integrity 12 months after transcervical fibroid ablation with the Sonata system. J Gynecol Surg. 2019;35(5):299–303.CrossRefPubMedPubMedCentral
Metadata
Title
Laparoscopic Radiofrequency Fibroid Ablation: A Review of Current Use and Future Applications
Authors
Natalie D. Cohen
Emily Lin
Jessica K. Shields
Kimberly A. Kho
Publication date
10-04-2024
Publisher
Springer US
Published in
Current Obstetrics and Gynecology Reports / Issue 2/2024
Electronic ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-024-00382-1

Other articles of this Issue 2/2024

Current Obstetrics and Gynecology Reports 2/2024 Go to the issue

REVIEW

Endometrial Determinism of Endometriosis: An Unnecessary Adjunct to Retrograde Menstruation

REVIEW

Contraception and Menstrual Management in Transmasculine and Gender-Diverse Individuals

REVIEW

Surgical Treatment of Adenomyosis

REVIEW

Pregnancy in Transmasculine, Non-binary, and Gender Expansive Patients

REVIEW

Role of Immunological Testing in Infertility

Review

Use of Simulation to Teach Obstetrics and Gynecology Residents How to Care for Transgender & Gender Diverse Patients